Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychedelic drug
Pharma
Astellas, Otsuka, Takeda—Fierce Pharma Asia
Astellas pulls IRA lawsuit. Otsuka buys a psychedelic biotech. Takeda is ordered pay AbbVie nearly $480 million.
Angus Liu
Sep 8, 2023 9:50am
Canadian company hopes to take psychedelic therapy mainstream
Jan 24, 2023 6:25am
Sublingual psychedelic startup nets $60M for depression trials
Nov 8, 2022 7:30am
Seelos eyes chronic ketamine dosing with sublingual candidate
Nov 30, 2021 9:45am
PharmaTher, TSRL ally to create patches to deliver psychedelics
Jun 7, 2021 7:50am
IntelGenx to pair its VersaFilm with prescription psychedelics
Sep 16, 2020 9:05am
